Drugs for Polyneuropathy (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 258)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Imipramine |
Approved |
Phase 4 |
|
50-49-7 |
3696 |
Synonyms:
1-(3-Dimethylaminopropyl)-4,5-dihydro-2,3,6,7-dibenzazepine
10,11-Dihydro-5-(3-(dimethylamino)propyl)-5H-dibenz[b,f]azepine
10,11-dihydro-N,N-dimethyl-5H-dibenz[b,f]azepine-5-propanamine
10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine
10,11-Dihydro-N,N-dimethyl-5H-dibenz[b,f]azepine-5-propanamine
113-52-0 (mono-hydrochloride)
2,2'-(3-Dimethylaminopropylimino)bibenzyl
2,2'-(3-Dimethylaminopropylimino)dibenzyl
3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine
3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N-dimethylpropan-1-amine
3-(5H-dibenzo[b,F]AZEPIN-5-yl)-N,N-dimethylpropan-1-amine
5-(3-(Dimethylamino)propyl)-10,11-dihydro-5H-dibenz(b,f)azepine
5-(3-Dimethylaminopropyl)-10,11-dihydro-5H-dibenzo(b,f)azepine
5,6-Dihydro-N-(3-(dimethylamino)propyl)-11H-dibenz(b,e)azepine
5,6-Dihydro-N-[3-(dimethylamino)propyl]-11H-dibenz[b,e]azepine
5-[3-(dimethylamino)propyl]-10,11-dihydro-5H-dibenz[b,f]azepine
5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine
50-49-7
5H-Dibenz(b,f)azepine,5-[3-(dimethylamino)propyl]-10,11-dihydro-mixed with ethyl alcohol
5H-Dibenz(b,f)azepine-5-propanamine, 10,11-dihydro-N,N-dimethyl- (9CI)
AB00053486
AC1L1GIE
Antideprin
Berkomine
BIDD:GT0116
BPBio1_000313
BRD-K38436528-003-05-5
BRN 0256892
BSPBio_000283
BSPBio_002172
C07049
CAS-113-52-0
CCRIS 9173
Censtim
Censtin
CHEBI:47499
CHEMBL11
Chimoreptin
CID3696
CPD-11438
D08070
DB00458
DB08002
Declomipramine
Dimipressin
DivK1c_000559
Dpid
DPID
Dynaprin
Dyna-zina
Dyna-Zina
EINECS 200-042-1
Estraldine
Eupramin
Feinalmin
G-22355
HMS2089G08
HSDB 3100
IDI1_000559
IM
Imavate
Imidobenzyle
Imilanyle
Imipramin
Imipramina
Imipramina [INN-Spanish]
Imipramina [Italian]
imipramine
Imipramine
Imipramine (INN)
Imipramine [INN:BAN]
Imipramine Hcl
Imipramine hydrochloride
Imipramine monohydrochloride
Imipraminum
Imipraminum [INN-Latin]
Imiprin
Imizin
Imizine
Imizinum
|
Impramine
InChI=1/C19H24N2/c1-20(2)14-7-15-21-18-10-5-3-8-16(18)12-13-17-9-4-6-11-19(17)21/h3-6,8-11H,7,12-15H2,1-2H
Intalpram
Iramil
Irmin
Janimine
Janimine (hydrochloride)
KBio1_000559
KBio2_001395
KBio2_003963
KBio2_006531
KBio3_001392
KBioGR_000391
KBioSS_001395
L000739
Lofepramine
Lopac0_000702
Lopac-I-7379
LS-60467
Melipramin
Melipramine
MolPort-001-783-692
N-(.gamma.-Dimethylaminopropyl)iminodibenzyl
N-(3-Dimethylaminopropyl)-o-iminodibenzyl
N-(gamma-Dimethylaminopropyl)iminodibenzyl
N-(g-Dimethylaminopropyl)iminodibenzyl
N-(γ-dimethylaminopropyl)iminodibenzyl
NCGC00015563-01
NCGC00015563-02
NCGC00015563-03
NCGC00015563-09
NCGC00024253-03
NCGC00024253-04
nchembio747-comp8
Nelipramin
NINDS_000559
Norchlorimipramine
Norfranil
NSC 169866
NSC169866
Oprea1_200908
Pramine
Prazepine
Presamine
Prestwick0_000072
Prestwick1_000072
Prestwick2_000072
Prestwick3_000072
Promiben
Pryleugan
Psychoforin
Sk-Pramine
SK-Pramine
SPBio_001059
SPBio_002204
Spectrum_000915
Spectrum2_000990
Spectrum3_000466
Spectrum4_000016
Spectrum5_000864
Surmontil
Surplix
Teperine
Timolet
Tipramine
Tofranil
Tofranil (free base)
Tofranil (hydrochloride)
Tofranil (TN)
Tofranil base
Tofranil, base
Tofranil, Base
Tofraniln A
Tofranil-Pm
Tofranil-PM
Tofranil-PM (imipramine pamoate)
Trimipramine maleate
Trimipramine Maleate
UNII-OGG85SX4E4
WLN: T C676 BN&T&J B3N1&1
|
|
2 |
|
Cilostazol |
Approved, Investigational |
Phase 4 |
|
73963-72-1 |
2754 |
Synonyms:
3,4-dihydro-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-2(1H)-quinolinone
3,4-dihydro-6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-2(1H)-quinolinone
3,4-Dihydro-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-2(1H)-quinolinone
6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydro-2(1H)-quinolinone
6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydro-2(1H)-quinolinone
6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydrocarbostyril
6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydrocarbostyril
6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxyl)-3,4-dihydrocarobostyril
6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)-butoxy]-3,4-dihydro-1H-quinolin-2-one
6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)-butoxy]-3,4-dihydro-2(1H)-quinolinone
6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydroquinolin-2(1H)-one
6-[4-(1-cyclohexyltetrazol-5-yl)butoxy]-3,4-dihydro-1H-quinolin-2-one
73963-72-1
89332-50-3
AC1L1EE2
AC-4334
BRD-K67017579-001-04-2
BRD-K67017579-001-05-9
BRD-K67017579-001-07-5
BRD-K67017579-001-13-3
BRN 3632107
BSPBio_002759
C 0737
C045645
C0737_SIGMA
C20H27N5O2
CHEBI:31401
CHEMBL799
CID2754
cilostazol
Cilostazol
Cilostazol (JP15/USAN/INN)
Cilostazol [INN:JAN]
Cilostazole
Cilostazolum
Cilostazolum [INN-Latin]
CL23867
CPD000058428
D01896
DB01166
EU-0100218
HMS1922N15
HMS2093M14
|
KBio3_002259
KBioGR_001184
Lopac0_000218
Lopac-C-0737
LS-142693
MLS000028470
MLS000758281
MLS000759507
MLS001076067
MLS002153891
MolPort-001-758-007
NCGC00015207-01
NCGC00015207-02
NCGC00015207-06
NCGC00015207-10
NCGC00022153-02
NCGC00022153-04
NCGC00022153-05
NCGC00022153-06
NCGC00022153-07
OPC 13013
OPC 21
OPC-13013
OPC-21
Otsuka brand of cilostazol
Pletaal
Pletal
Pletal (TN)
Pletal, Cilostazol
S1294_Selleck
SAM001246734
SAM001247085
SMR000058428
SPBio_001256
SPECTRUM1505230
Spectrum2_001118
Spectrum3_001170
Spectrum4_000772
Spectrum5_001762
TL8005113
Tocris-1692
UNII-N7Z035406B
ZINC01552174
|
|
3 |
|
Acetylcholine |
Approved, Investigational |
Phase 4 |
|
51-84-3 |
187 |
Synonyms:
2-(Acetyloxy)-N,N,N-trimethylethanaminium
Acetilcolina cusi
Acetyl choline ion
Acetylcholine bromide
Acetylcholine cation
acetylcholine chloride
Acetylcholine chloride
Acetylcholine fluoride
Acetylcholine hydroxide
Acetylcholine iodide
Acetylcholine L tartrate
Acetylcholine L-tartrate
Acetylcholine perchlorate
Acetylcholine picrate
Acetylcholine picrate (1:1)
Acetylcholine sulfate (1:1)
Acetylcholinium: acetyl-choline
ACh
Alcon brand OF acetylcholine chloride
|
Azetylcholin
Bournonville brand OF acetylcholine chloride
Bromide, acetylcholine
Bromoacetylcholine
Chloroacetylcholine
Choline acetate
Choline acetate (ester)
Choline acetic acid
Ciba vision brand OF acetylcholine chloride
Cusi, acetilcolina
Fluoride, acetylcholine
Hydroxide, acetylcholine
Iodide, acetylcholine
Iolab brand OF acetylcholine chloride
L-Tartrate, acetylcholine
Miochol
O-Acetylcholine
Perchlorate, acetylcholine
|
|
4 |
|
Citalopram |
Approved |
Phase 4 |
|
59729-33-8 |
2771 |
Synonyms:
[3H]Citalopram
1-(3-(Dimethylamino)propyl)-1-(p-fluorophenyl)-5-phthalancarbonitrile
1,3-dihydro[3,4]benzofuran-5-carbonitrile
1,3-Dihydro-1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-5-isobenzofurancarbonitrile
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile
59729-33-8
AB00513896
AC-12214
AC1L1EFH
AE-641/00603021
Akarin
Bonitrile
BPBio1_000929
BRD-A47598013-004-02-0
BSPBio_000843
C07572
C20H21FN2O
Celapram
Celexa
Celius
CHEBI:3723
CHEMBL549
Ciazil
CID2771
Cilift
Cipram
Cipramil
Ciprapine
Citabax
Citadur
Citadur (TN)
Citalec
citalopram
Citalopram
Citalopram (USP/INN)
Citalopram [Celexa]
Citalopram [INN:BAN]
Citalopram hydrobromide
Citalopram Hydrobromide
Citalopramum
Citalopramum [INN-Latin]
|
Citol
Citopam
Citox
Citrol
CPD000465669
Cytalopram
D07704
Dalsan
DB00215
EINECS 261-891-1
Elopram
Escitalopram
HMS2090O09
HMS2093A14
Humorup
I01-0382
InChI=1/C20H21FN2O/c1-23(2)11-3-10-20(17-5-7-18(21)8-6-17)19-9-4-15(13-22)12-16(19)14-24-20/h4-9,12H,3,10-11,14H2,1-2H3
L001223
Lexapro
Lopac0_000258
LS-84327
Lu 10-171
Lu-10-171
MolPort-003-666-794
NCGC00015267-07
NCGC00025160-02
Nitalapram
Oropram
Pramcit
Prestwick3_000692
Recital
SAM002589960
Seropram
ST069372
STL058639
Talam
Talohexal
Temperax
UNII-0DHU5B8D6V
Vodelax
Zentius
Zetalo
|
|
5 |
|
Oxcarbazepine |
Approved |
Phase 4 |
|
28721-07-5 |
34312 |
Synonyms:
10,11-Dihydro-10-oxo-5H-debenz(b,f)azepine-5-carboxamide
10,11-dihydro-10-oxo-5H-Dibenz(b,F)azepine-5-carboxamide
10,11-Dihydro-10-oxo-5H-dibenz(b,f)azepine-5-carboxamide
10,11-Dihydro-10-oxo-5h-dibenz[b,f]azepine-5-carboxamide
10,11-Dihydro-10-oxo-5H-dibenzo[b,f]azepine-5-carboxamide
10-Oxo-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide
28721-07-5
5-oxo-6H-benzo[b][1]benzazepine-11-carboxamide
AB1004555
AC1L1RCU
AC1Q6NA8
AC-3483
BIDD:GT0078
Bio-0527
BSPBio_003457
C036006
C07492
CHEMBL1068
CID34312
CPD000048684
D00533
DB00776
Desitin brand of oxcarbazepine
Desitin brand OF oxcarbazepine
EINECS 249-188-8
Epilexter
Epliga
GP 47680
GP-47680
HMS1922H17
HMS2051O04
HMS2090F13
HMS2093E10
HSDB 7524
I06-0072
KBio2_002155
KBio2_004723
KBio2_007291
KBio3_002677
KBioGR_001248
KBioSS_002155
KIN-493
|
LS-60365
MLS000084586
MLS000759520
MLS001201742
MolPort-001-685-316
NCGC00065934-02
NCGC00065934-03
NCGC00065934-04
Novartis brand of oxcarbazepine
Novartis brand OF oxcarbazepine
O0363
O3764_SIGMA
OCBZ
Oxacarbazepine
Oxcarbamazepine
Oxcarbazepime
Oxcarbazepina
Oxcarbazepina [INN-Spanish]
oxcarbazepine
Oxcarbazepine
OXCARBAZEPINE
Oxcarbazepine (USAN/INN)
Oxcarbazepine [INN]
Oxcarbazepinum
Oxcarbazepinum [INN-Latin]
S1391_Selleck
SAM001246754
SMR000048684
SPBio_000345
Spectrum_001675
SPECTRUM1504243
Spectrum2_000483
Spectrum3_001669
Spectrum4_000634
Spectrum5_001869
SPN-804
STK594696
Timox
Trileptal
Trileptal (TN)
UNII-VZI5B1W380
ZINC00004724
|
|
6 |
|
Nortriptyline |
Approved |
Phase 4 |
|
72-69-5 |
4543 |
Synonyms:
(2)10,11-Dihydro-N-methyl-5H-dibenzo[a,d]cycloheptene-.delta.5.gamma.-propylamine
10,11-Dihydro-5-(3-methylaminopropylidene)-5H-dibenzo(a,d)(1,4)cycloheptene
10,11-Dihydro-N-methyl-5H-dibenzo(a,d)cycloheptene-delta(5,gamma)-propylamine
10,11-dihydro-N-Methyl-5H-dibenzo[a,D]cycloheptene-delta(5,g)-propylamine
10,11-dihydro-N-methyl-5H-dibenzo[a,d]cycloheptene-Delta(5,gamma)-propylamine
10,11-dihydro-N-Methyl-5H-dibenzo[a,D]cycloheptene-Delta(5,gamma)-propylamine
10,11-dihydro-N-Methyl-5H-dibenzo[a,D]cycloheptene-δ(5,g)-propylamine
10,11-dihydro-N-Methyl-5H-dibenzo[a,D]cycloheptene-δ(5,γ)-propylamine
10,11-dihydro-N-methyl-5H-dibenzo[a,d]cycloheptene-Δ5,γ-propylamine
3-(10,11-Dihydro-5H-dibenzo(a,d)cyclohepten-5-ylidene)-N-methylpropylamine
3-(10,11-dihydro-5H-dibenzo[a,d][7]annulen-5-ylidene)-N-methylpropan-1-amine
3-(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-ylidene)-N-methyl-1-propanamine
3-(10,11-dihydro-5H-dibenzo[a,D]Cyclohepten-5-ylidene)-N-methyl-1-propanamine
3-(10,11-Dihydro-5H-dibenzo[a,d]cyclohepten-5-ylidene)-N-methyl-1-propanamine
5-(3-(Methylamino)propylidene)dibenzo(a,e)cyclohepta(1,5)diene
5-(3-Methylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,d)cycloheptene
5-(alpha-Methylaminopropylidene)dibenzo(a,d)cyclohepta(1,4)diene
72-69-5
894-71-3
AB00052061
AC1L1IED
Acetexa
Allegron
Altilev
apo Nortriptyline
apo-Nortriptyline
Apotex brand OF nortriptyline hydrochloride
Ateben
Avantyl
Aventyl
AVENTYL HCL
BIDD:PXR0187
BPBio1_000076
BRD-K91263825-003-03-2
BRN 2216786
BSPBio_000068
BSPBio_002111
C07274
CAS-894-71-3
CCRIS 9175
CHEBI:7640
CHEMBL445
CID4543
D08288
DB00540
Demethylamitriptylene
Demethylamitriptyline
Demethylamitryptyline
Desitriptilina
Desitriptyline
Desmethylamitriptylin
Desmethylamitriptyline
Dista brand OF nortriptyline hydrochloride
DivK1c_000151
EINECS 200-788-8
Gen nortriptyline
Gen-nortriptyline
Genpharm brand OF nortriptyline hydrochloride
HMS1920B20
HMS2091J20
HMS500H13
Hydrochloride, nortriptyline
IDI1_000151
KBio1_000151
KBio2_001521
KBio2_004089
KBio2_006657
KBio3_001611
KBioGR_000870
KBioSS_001521
Lilly brand OF nortriptyline hydrochloride
Lopac0_000868
Lopac-N-7261
LS-60753
Lumbeck
Lundbeck brand OF nortriptyline hydrochloride
Mallinckrodt brand OF nortriptyline hydrochloride
MolPort-003-666-245
NCGC00014483
|
NCGC00014483-02
NCGC00014483-03
NCGC00014483-04
NCGC00014483-11
NCGC00024261-03
NCGC00024261-04
NCGC00024261-05
NCGC00024261-06
nchembio747-comp6
NCI169453
NCI60_001354
NCIOpen2_004361
NCIStruc1_000856
NCIStruc2_000700
NINDS_000151
N-Methyl-3-(10,11-dihydro-5H-dibenzo(a,d)cyclohepten-5-yliden)propylamin
Noramitriptyline
Norfenazin
Noritren
Nortrilen
Nortrilen (TN)
Nortriptilina
Nortriptilina [DCIT]
Nortriptylene hydrochloride
Nortriptylina
nortriptyline
Nortriptyline
Nortriptyline (INN)
Nortriptyline [INN:BAN]
Nortriptyline Hcl
Nortriptyline hydrochloride
Nortriptylinum
Nortriptylinum [INN-Latin]
Nortryptiline
Nortryptyline
Norzepine
novo Nortriptyline
novo-Nortriptyline
Novopharm brand OF nortriptyline hydrochloride
NSC169453
NSC-169453
NSC78248
Nu nortriptyline
Nu pharm brand OF nortriptyline hydrochloride
Nu-nortriptyline
Nu-pharm brand OF nortriptyline hydrochloride
Pamelor
PAMELOR
Pamelor hydrochloride
Paxtibi
PDSP1_001805
PDSP2_001788
Pharmascience brand OF nortriptyline hydrochloride
PMS Nortriptyline
PMS-Nortriptyline
Prestwick0_000254
Prestwick1_000254
Prestwick2_000254
Prestwick3_000254
Psychostyl
QTL1_000063
ratio Nortriptyline
ratio-Nortriptyline
Ratiopharm brand OF nortriptyline hydrochloride
Reig jofre brand OF nortriptyline hydrochloride
Sensaval
Sensival Ventyl
Sesaval
SPBio_001093
SPBio_002287
Spectrum_001041
SPECTRUM1500442
Spectrum2_000997
Spectrum3_000526
Spectrum4_000455
Spectrum5_001377
UNII-BL03SY4LXB
Vividyl
|
|
7 |
|
Mexiletine |
Approved, Investigational |
Phase 4 |
|
31828-71-4 |
4178 |
Synonyms:
(+-)-1-(2,6-dimethylphenoxy)propan-2-amine
(+-)-1-(2,6-Dimethylphenoxy)propan-2-amine
(±)-1-(2,6-dimethylphenoxy)propan-2-amine
(2Rs)-1-(2,6-Dimethylphenoxy)-2-aminopropane
(2RS)-1-(2,6-dimethylphenoxy)-2-aminopropane
1-(2',6'-dimethylphenoxy)-2-aminopropane
1-(2',6'-Dimethylphenoxy)-2-aminopropane
1-(2,6-dimethylphenoxy)-2-propanamine
1-(2,6-Dimethylphenoxy)-2-propanamine
1-(2,6-dimethylphenoxy)propan-2-amine
1-methyl-2-(2,6-xylyloxy)ethanamine
1-Methyl-2-(2,6-xylyloxy)ethanamine
1-Methyl-2-(2,6-xylyloxy)ethylamine
2-(2-aminopropoxy)-1,3-dimethylbenzene
2-(2-Aminopropoxy)-1,3-DiMethyl-Benzene Hydrochloride
31828-71-4
5370-01-4 (hydrochloride)
AB00053683
AC1L1HL7
AC1Q2BC5
AC1Q2BC6
Boehringer ingelheim brand OF mexiletine hydrochloride
BPBio1_000026
BRD-A64092382-003-04-3
BRN 2092205
BSPBio_000022
BSPBio_002254
C07220
CHEBI:115958
CHEBI:6916
CHEMBL558
CID4178
D08215
DB00379
DivK1c_000834
EINECS 250-825-7
I01-6374
IDI1_000834
KBio1_000834
KBio2_002082
KBio2_004650
KBio2_007218
|
KBio3_001474
KBioGR_001270
KBioSS_002082
KO1173
KO-1173
KOE-1173
Lopac0_000784
LS-68257
Mexiletene
Mexiletina
Mexiletina [INN-Spanish]
Mexiletine
Mexilétine
Mexiletine (INN)
Mexiletine [INN:BAN]
Mexiletine HCL
Mexiletine hydrochloride
Mexiletinum
Mexiletinum [INN-Latin]
Mexilitine
Mexitil
Mexitil PL
Mexityl
MolPort-001-790-944
NCGC00015659-04
NCGC00162253-01
NCGC00162253-02
NINDS_000834
novo Mexiletine
novo-Mexiletine
Novopharm brand OF mexiletine hydrochloride
Prestwick0_000241
Prestwick1_000241
Prestwick2_000241
Prestwick3_000241
SBB070242
SPBio_002241
Spectrum_001602
Spectrum3_000727
Spectrum4_000795
Spectrum5_001279
UNII-1U511HHV4Z
|
|
8 |
|
Prednisolone phosphate |
Approved, Vet_approved |
Phase 4 |
|
302-25-0 |
|
Synonyms:
Prednisolone 21-(dihydrogen phosphate)
Prednisolone 21-monophosphate
|
Prednisolone 21-phosphate
|
|
9 |
|
Methylprednisolone |
Approved, Vet_approved |
Phase 4 |
|
83-43-2 |
6741 |
Synonyms:
(6a,11b)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
(6α,11β)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione
.DELTA.1-6.alpha.-Methylhydrocortisone
11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methyl-1,4-pregnadiene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
121673-01-6
1-dehydro-6alpha-Methylhydrocortisone
1-Dehydro-6alpha-methylhydrocortisone
1-dehydro-6a-Methylhydrocortisone
1-dehydro-6α-methylhydrocortisone
4-08-00-03498 (Beilstein Handbook Reference)
46436_FLUKA
46436_RIEDEL
570-35-4
6 Methylprednisolone
6.alpha.-Methylprednisolone
6923-42-8
6alpha-Methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione
6alpha-methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
6alpha-Methylprednisolone
6-alpha-Methylprednisolone
6a-Methyl-11b,17a,21-triol-1,4-pregnadiene-3,20-dione
6-Methylprednisolone
6α-methyl-11β,17α,21-triol-1,4-pregnadiene-3,20-dione
83-43-2
AC1L1N7A
Artisone-wyeth
Artisone-Wyeth
Besonia
Bio-0658
BPBio1_000174
BRD-K35240538-001-03-1
BRN 2340300
BSPBio_000158
CHEBI:6888
CHEMBL650
CID6741
CPD000058330
D00407
D008775
DB00959
delta(1)-6alpha-Methylhydrocortisone
Delta(1)-6alpha-Methylhydrocortisone
delta(1)-6a-Methylhydrocortisone
delta(sup 1)-6-alpha-Methylhydrocortisone
Depo-Medrol (acetate)
Dopomedrol
EINECS 201-476-4
Esametone
Firmacort
HMS1568H20
HMS2090B13
HSDB 3127
Lemod
LMST02030178
LS-118498
M0639_SIGMA
M1665
Medesone
Medixon
Medlone 21
Medrate
Medric acid
|
Medrol
Medrol (TN)
Medrol adt pak
Medrol Adt Pak
Medrol dosepak
Medrol Dosepak
Medrol, Solu-Medrol, Medrone, Methylprednisolone
Medrone
MEPRDL
Mesopren
Metastab
Methyleneprednisolone
Methylprednisolon
methylprednisolone
Methylprednisolone
Methylprednisolone (JP15/USP/INN)
Methylprednisolone [USAN:INN:BAN:JAN]
Methylprednisolone, 6-alpha
Methylprednisolonum
Methylprednisolonum [INN-Latin]
methylprenisolone
Metilbetasone
Metilprednisolona
Metilprednisolona [INN-Spanish]
Metilprednisolone
Metilprednisolone [Dcit]
Metilprednisolone [DCIT]
Metipred
Metrisone
Metrocort
Metysolon
MLS000028541
MLS001148159
MLS002207191
Moderin
MolPort-002-528-554
NCGC00022735-03
NCI60_001657
Nirypan
Noretona
NSC19987
NSC-19987
Predni N Tablinen
Prednol- L
Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl- (8CI)
Prestwick_622
Prestwick0_000279
Prestwick1_000279
Prestwick2_000279
Prestwick3_000279
Promacortine
Reactenol
S1733_Selleck
SAM002589984
Sieropresol
SMR000058330
Solomet
SPBio_002377
Summicort
Suprametil
U 7532
UNII-X4W7ZR7023
Urbason
Urbasone
Wyacort
ZINC03875560
δ(1)-6a-methylhydrocortisone
δ(1)-6α-methylhydrocortisone
|
|
10 |
|
Methylprednisolone hemisuccinate |
Approved |
Phase 4 |
|
2921-57-5 |
|
Synonyms:
Methylprednisolone hydrogen succinate
|
Methylprednisolone succinate
|
|
11 |
|
Prednisolone acetate |
Approved, Vet_approved |
Phase 4 |
|
52-21-1 |
|
12 |
|
Prednisolone |
Approved, Vet_approved |
Phase 4 |
|
50-24-8 |
5755 |
Synonyms:
(11b)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione
(11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione
(11β)-11,17,21-trihydroxypregna-1,4-diene-3,20-dione
.DELTA.1-Cortisol
.DELTA.1-Dehydrocortisol
.DELTA.1-Dehydrohydrocortisone
.DELTA.1-Hydrocortisone
.delta.-Cortef
.delta.-Stab
1,2-Dehydrohydrocortisone
1,4-Pregnadiene-11b,17a,21-triol-3,20-dione
1,4-Pregnadiene-11beta,17alpha,21-triol-3,20-dione
1,4-pregnadiene-11β,17α,21-triol-3,20-dione
1,4-Pregnadiene-11β,17α,21-triol-3,20-dione
1,4-Pregnadiene-3,20-dione-11b,17a,21-triol
1,4-Pregnadiene-3,20-dione-11beta,17alpha,21-triol
1,4-pregnadiene-3,20-dione-11β,17α,21-triol
1,4-Pregnadiene-3,20-dione-11β,17α,21-triol
1-Dehydrocortisol
1-Dehydrohydrocortisone
3,20-dioxo-11b,17a,21-Trihydroxy-1,4-pregnadiene
3,20-dioxo-11beta,17alpha,21-Trihydroxy-1,4-pregnadiene
3,20-dioxo-11β,17α,21-trihydroxy-1,4-pregnadiene
46656_FLUKA
46656_RIEDEL
50-24-8
58201-11-9
8056-11-9
AC-1773
AC1L1L2E
Ak-Pred
Ak-Tate
Alphadrol
Articulose-50
Bio-0666
BPBio1_000164
BRD-K98039984-001-03-0
BRN 1354103
BSPBio_000148
Bubbli-Pred
C07369
CCRIS 980
CHEBI:8378
CHEMBL131
CID5755
Codelcortone
Co-Hydeltra
CO-Hydeltra
component of Ataraxoid
component of K-Predne-Dome
Cordrol
Cortalone
Cotogesic
Cotolone
CPD000718761
D00472
D011239
DB00860
Decaprednil
Decortin H
Delcortol
Delta F
delta(1)-Cortisol
delta(1)-Dehydrocortisol
Delta(1)-Dehydrocortisol
delta(1)-Dehydrohydrocortisone
Delta(1)-dehydrohydrocortisone
Delta(1)-Dehydrohydrocortisone
delta(1)-Hydrocortisone
Delta(1)-Hydrocortisone
delta(sup 1)-Cortisol
delta(sup 1)-Dehydrocortisol
delta(sup 1)-Dehydrohydrocortisone
delta(sup 1)-Hydrocortisone
Delta-Cortef
Delta-Cortef (TN)
Deltacortenol
Deltacortril
Deltacortril Enteric
delta-dehydrocortisol
delta-dehydrohydrocortisone
Delta-Ef-Cortelan
delta-hydrocortisone
Deltahydrocortisone
Deltasolone
Delta-stab
Delta-Stab
Deltisilone
Depo-Medrol
Derpo Pd
Derpo PD
Dexa-Cortidelt hostacortin H
Dexa-Cortidelt Hostacortin H
Di adreson F
Di Adreson F
Di-adreson F
Di-Adreson F
Di-adreson-F
DiAdresonF
Di-Adreson-F
Dicortol
Donisolone
Dydeltrone
Eazolin D
Econopred
Econopred Plus
EINECS 200-021-7
Erbacort
Erbasona
Estilsona
Fernisolone
Fernisolone P
Fernisolone-P
Flamasone
HMS1568H10
HMS2090J05
Hostacortin H
HSDB 3385
Hydeltra
Hydeltrasol
Hydeltra-Tba
Hydeltrone
|
Hydrodeltalone
Hydrodeltisone
Hydroretrocortin
Hydroretrocortine
Inflamase Forte
Inflamase Mild
I-Pred
K 1557
Key-Pred
Klismacort
Lentosone
Lite Pred
LMST02030179
LS-7669
Medrol
Medrol Acetate
Metacortandralone
Methylprednisolone acetate
Methylprednisolone Acetate
Meticortelone
Meti-Derm
Metreton
MLS001304083
MLS002154250
MLS002207037
MolPort-002-507-147
M-Predrol
NCGC00179649-01
Neo-Delta-Cortef
Nisolone
Nor-Pred T.B.A.
NSC 9120
NSC9120
NSC9900
Ocu-Pred
Ocu-Pred Forte
Ophtho-Tate
Orapred
P0152_SIGMA
P0637
P6004_SIGMA
Panafcortelone
Paracortol
Paracotol
Pediapred
Poly-Pred
PRDL
Precortalon
Precortancyl
Precortilon
Precortisyl
Pred Forte
Pred Mild
Predair
Predair A
Predair Forte
Predalone 50
Predalone T.B.A.
Predate
Predate Tba
Predate-50
Predcor-25
Predcor-50
Predcor-Tba
PRED-G
Predisolone sodium phosphate
Predisolone Sodium Phosphate
Predne-Dome
Prednelan
Prednicen
Predni-Dome
Predniliderm
Predniretard
Prednis
Prednisolona
Prednisolona [INN-Spanish]
prednisolone
Prednisolone
Prednisolone (anhydrous)
Prednisolone (JP15/USP/INN)
Prednisolone [INN:BAN:JAN]
Prednisolone acetate
Prednisolone Acetate
Prednisolone sodium phosphate
Prednisolone Sodium Phosphate
Prednisolone tebutate
Prednisolone Tebutate
Prednisolonum
Prednisolonum [INN-Latin]
Predonin
Predonine
Prelone
Prenolone
Prestwick_404
Prestwick0_000274
Prestwick1_000274
Prestwick2_000274
Prestwick3_000274
Rolisone
S1737_Selleck
SAM002264639
Scherisolon
SMR000718761
Solone
SPBio_002367
Steran
Sterane
Sterolone
Supercortisol
Ulacort
Ultra Pred
Ultracorten H
Ultracortene H
Ultracortene-H
Ultracortene-hydrogen
Ultracortene-Hydrogen
UNII-9PHQ9Y1OLM
ZINC03833821
δ(1)-dehydrocortisol
δ(1)-dehydrohydrocortisone
δ(1)-hydrocortisone
|
|
13 |
|
Tadalafil |
Approved, Investigational |
Phase 4 |
|
171596-29-5 |
110635 |
Synonyms:
(6R,12aR)-2,3,6,7,12,12a-Hexahydro-2-methyl-6-(3,4-(methylenedioxy)phenyl) pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione
(6R,12AR)-2,3,6,7,12,12a-hexahydro-2-methyl-6-(3,4-(methylenedioxy)phenyl) pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione
(6R,12aR)-2,3,6,7,12,12a-Hexahydro-2-methyl-6-(3,4-methylenedioxyphenyl)pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione
(6R-trans)-6-(1,3-Benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methyl-pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione
171596-29-5
1xoz
351, IC
6-benzo[1,3]DIOXOL-5-yl-2-methyl-2,3,6,7,12,12a-hexahydro-pyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione
AC1L380B
Acdirca
Adcirca
ADCIRCA
C429886
CHEBI:41488
CHEMBL779
Cialis
Cialis (TN)
Cialis, GF 196960, IC 351, ICOS 351, Tadalafil
CID110635
CPD000466321
D02008
DB00820
FT-0080116
GF 196960
GF-196960
HMS2051N17
|
HSDB 7303
IC 351
Ic351
IC-351
ICOS 351
KS-1117
Lilly brand of tadalafil
LS-186558
LS-187015
LS-187770
MLS000759426
MLS001165782
MLS001195644
MLS001424132
MolPort-002-885-864
S1512_Selleck
SAM001246586
SMR000466321
Tadalafil
Tadalafil (JAN/USAN/INN)
Tadalafil [USAN]
Tadalafilo
Tadanafil
UNII-742SXX0ICT
ZINC03993855
|
|
14 |
|
Nimodipine |
Approved, Investigational |
Phase 4 |
|
66085-59-4 |
4497 |
Synonyms:
1,4-Dihydro-2,6-dimethyl-4-(3&prime
1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid
1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid 2-methoxyethyl 1-methylethyl ester
1-methylethyl 2-(methyloxy)ethyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate 3-beta-methoxyethyl ester 5-isopropyl ester
2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate 3-b-methoxyethyl ester 5-isopropyl ester
2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate 3-β-methoxyethyl ester 5-isopropyl ester
2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-methoxyethyl ester 5-isopropyl ester
2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-b-methoxyethyl ester 5-isopropyl ester
2,6-dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-β-methoxyethyl ester 5-isopropyl ester
2,6-Dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-β-methoxyethyl ester 5-isopropyl ester
2-methoxyethyl propan-2-yl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
2-Methoxyethyl-1-methylethyl ester
3-(2-methoxyethyl) 5-propan-2-yl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
3,5-pyridinecarboxylic acid 2-methoxyethyl 1-methylethyl ester
3,5-pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl), 2-methoxyethyl 1-methylethyl ester
3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 2-methoxyethyl 1-methylethyl ester
3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-,2-methoxyethyl 1-methylethyl ester
3-O-(2-methoxyethyl) 5-O-propan-2-yl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidyl]-N,N-dimethyl-2,2-diphenyl-butanamide
66085-59-4
9736, Bay e
AB00513963
AC-11694
AC1L1IAS
AC1Q4G7S
Admon
Almirall brand OF nimodipine
Almirall Brand of Nimodipine
Alpharma brand OF nimodipine
Alpharma Brand of Nimodipine
andromaco Brand OF nimodipine
Andromaco Brand of Nimodipine
BAY e 9736
Bay-E 9736
Bay-e-9736
Bayer brand OF nimodipine
Bayer Brand of Nimodipine
Bayvit brand OF nimodipine
Bayvit Brand of Nimodipine
Bayvit, nimodipino
Bio-0178
Bio1_000118
Bio1_000607
Bio1_001096
Bio2_000117
Bio2_000597
BPBio1_000876
Brainal
BRD-A58048407-001-06-3
BRN 0459792
BSPBio_000796
BSPBio_001397
BSPBio_002412
C07267
C21H26N2O7
Calnit
Cantabria brand OF nimodipine
Cantabria Brand of Nimodipine
CBiol_001832
CHEBI:160965
CHEBI:465248
CHEMBL1428
CHEMBL40792
CID4497
CPD000058300
D00438
D009553
DB00393
DivK1c_006812
DRG-0139
e 9736, Bay
EG-1961
EINECS 266-127-0
Elan brand OF nimodipine
Elan Brand of Nimodipine
Esteve brand OF nimodipine
Esteve Brand of Nimodipine
EU-0100891
FT-0082761
Hexal brand OF nimodipine
Hexal Brand of Nimodipine
Hexal, nimodipin
HMS1361F19
HMS1570H18
HMS1791F19
HMS1922E04
HMS1989F19
HMS2052M05
HMS2089H13
HMS2093G11
I06-0230
|
IDI1_033867
isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate
Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate
Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid
isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate
Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate
Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylic acid
KBio1_001756
KBio2_000117
KBio2_002403
KBio2_002685
KBio2_004971
KBio2_005253
KBio2_007539
KBio3_000233
KBio3_000234
KBio3_001632
KBioGR_000117
KBioGR_001262
KBioSS_000117
KBioSS_002408
Kenesil
Lopac0_000891
LS-131292
MLS000069381
MLS000863294
MLS001076550
MLS002154061
MLS002172461
Modus
MolPort-001-840-190
N-149
N149_SIGMA
NCGC00015714-04
NCGC00015714-12
NCGC00024675-02
NCGC00024675-03
NCGC00024675-04
NCGC00024675-05
NCGC00024675-06
NCGC00024675-07
NCGC00024675-08
NCGC00024675-09
nchembio.476-comp9
nchembio.79-comp6
Nimodipin hexal
Nimodipin Hexal
Nimodipin isis
Nimodipin ISIS
nimodipine
Nimodipine
Nimodipine (USAN/INN)
Nimodipine [USAN:BAN:INN]
Nimodipin-isis
NimodipinISIS
Nimodipin-ISIS
Nimodipino
Nimodipino [INN-Spanish]
nimodipino Bayvit
Nimodipino Bayvit
Nimodipinum
Nimodipinum [INN-Latin]
NimoGel
Nimotop
NIMOTOP (TN)
Nimotop(TM)
Nimotop, Nimodipine
-nitrophenyl)-3,5-pyridinedicarboxylic acid 2-methoxyethyl-1-methylethyl Ester
Nymalize
Periplum
Periplum, Nimotop, BRN 0459792, DRG-0139
Prestwick0_000918
Prestwick1_000918
Prestwick2_000918
Prestwick3_000918
Remontal
S1747_Selleck
SAM001246890
SMR000058300
SPBio_001464
SPBio_002985
SpecPlus_000716
Spectrum_001880
SPECTRUM1503600
Spectrum2_001562
Spectrum3_000766
Spectrum4_000791
Spectrum5_001687
STK642934
UNII-57WA9QZ5WH
Vita brand OF nimodipine
Vita Brand of Nimodipine
|
|
15 |
|
Ranolazine |
Approved, Investigational |
Phase 4 |
|
142387-99-3, 95635-55-5 |
56959 |
Synonyms:
( -)-Ranolazine
(-)-Ranolazine
142387-99-3
95635-55-5
AC-1673
AC1L1M17
AC1Q5LYD
BRD-A97674275-001-01-9
BSPBio_002276
CHEMBL1404
CID56959
CVT-303
D05700
DB00243
Dihydrochloride, ranolazine
HCL, Ranolazine
HMS1922F16
HMS2090L09
HMS2093D21
Hydrochloride, ranolazine
I01-2008
I06-0160
KEG-1295
Latixa
Lopac0_001062
LS-187267
MLS002154149
MolPort-003-666-653
N-(2,6-dimethylphenyl)-2-[4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl]acetamide
|
N-(2,6-Dimethylphenyl)-4-(2-hydroxy-3-(2-methoxyphenoxy)propyl)-1-piperazineacetamide
NCGC00015897-05
NCGC00095177-01
NCGC00095177-02
NCGC00095177-03
RAN D
Ran4
Ranexa
Ranexa (TN)
Ranexa, Ranolazine
Ranolazina
ranolazine
Ranolazine
RANOLAZINE
Ranolazine (USAN/INN)
Ranolazine 2HCl
Ranolazine 2HCL
Ranolazine dihydrochloride
Ranolazine Dihydrochloride
Ranolazine HCL
Ranolazine hydrochloride
Renolazine
RS-43285
RS-43285-003
S1799_Selleck
SMR000857382
SPECTRUM1505366
UNII-A6IEZ5M406
|
|
16 |
|
Vitamin A |
Approved, Nutraceutical, Vet_approved |
Phase 4 |
|
22737-96-8, 68-26-8, 11103-57-4 |
9904001 445354 |
Synonyms:
(11-cis,13-cis)-Retinol acetate
(13cis)-Retinol
(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol
(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraen-1-ol
(2Z,4E,6E,8E)-3,7-Dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol
(all-E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol
.alpha.lin
.alpha.sterol
.beta.-Retinol
[11,12-3H]-Retinol
11,13-Di-cis-vitamin a acetate
11103-57-4
11-cis-13-cis-Retinol acetate
11-cis-13-cis-Retinyl acetate
13123-33-6
1341-18-0
1406-67-3
17104-91-5
1rbp
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclchexen-1-yl)-2,4,6,8-nonatetraen-1-ol
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonate-traen-1-ol
3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol, (all-E)-Isomer
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)-2,4,6,8-nonatetraen-1-ol
4-06-00-04133 (Beilstein Handbook Reference)
53637-36-8
5979-23-7
68-26-8
95144_FLUKA
95144_SIGMA
95146_FLUKA
95146_SIGMA
AC-11701
AC1L9HU3
AC1Q7BU9
ACON
Afaxin
Agiolan
Agoncal
Alcohol 9,13-dimethyl-7-(1,1,5-trimethyl-6-cyclohexen-5-yl)-7,9,11,13-nonatetraen-15-ol
Alcovit A
alin
All Trans Retinol
All-trans retinol
ALL-TRANS RETINOL (SEE ALSO RETINOID PROJECT 1)
all-trans-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol
all-trans-retinol
all-trans-Retinol
all-trans-retinyl alcohol
all-trans-Retinyl alcohol
all-trans-Vitamin A
all-trans-vitamin A alcohol
all-trans-Vitamin A alcohol
all-trans-Vitamin A1
Alphalin
Alphasterol
A-Mulsal
Anatola
Anatola A
Anti-infective vitamin
Antixerophthalmic vitamin
Antixerophthalmisches Vitamin
Aoral
Apexol
Apostavit
Aquasol A Parenteral
Aquasynth
AR-1L3057
A-Sol
Atars
ATAV
Avibon
A-Vi-Pel
Avita
A-Vitan
Avitol
Axerol
Axerophthol
Axerophtholum
Bentavit A
beta-Retinol
BIDD:PXR0102
Biosterol
BRN 0403040
C00473
C17276
C20H30O
CCRIS 5444
CHEBI:17336
CHEMBL986
Chocola A
CID445354
Cylasphere
D014801
D06543
DB00162
Del-VI-A
Disatabs Tabs
Dofsol
Dohyfral A
EINECS 200-683-7
EINECS 234-328-2
Epiteliol
Hi-A-Vita
|
HMS1921B04
HMS2092L13
HMS501I08
Homagenets Aoral
Homagenets aorl
HSDB 815
Hydrovit A
IDI1_000486
Lard Factor
LMPR01090001
LPK
LS-1578
M.V.C. 9+3
M.V.I.-12
MLS001066379
MLS001074751
MolPort-001-785-962
Mvc Plus
Myvpack
NCGC00091784-01
NCGC00091784-02
NCGC00091784-03
NCGC00091784-04
NCGC00091784-05
NCGC00091784-06
Nio-A-Let
NSC 122759
NSC122759
Oleovitamin A
Ophthalamin
Plivit A
Prepalin
R7632_SIGMA
Retin-11,12-t2-ol (9CI)
retinol
Retinol
RETINOL
Retinol [INN:BAN]
Retinol solution
Retinol-(cellular-retinol-binding-protein)
Retinol, all-trans- (8CI)
Retinolo
Retinolo [DCIT]
Retinolum
Retinolum [INN-Latin]
Retrovitamin A
Ro-a-vit
Rovimix A 500
SDCCGMLS-0066724.P001
Sehkraft A
SMP2_000102
SMR000112036
Solu-A
SPECTRUM1501203
Spectrum5_000993
Spectrum5_001997
ST057232
Super A
Testavol
Testavol S
Thalasphere
trans-retinol
trans-Retinol acid (Vitamin A)
trans-Vitamin A alcohol
tROL
UNII-81G40H8B0T
UNII-G2SH0XKK91
Vaflol
Vafol
Veroftal
Vi-.alpha.
Vi-a
Vi-Alpha
Vi-Dom-A
Vio-A
Vitamin A
Vitamin- A
Vitamin A (Feed)
Vitamin A (USP)
Vitamin A alcohol
Vitamin- A alcohol
Vitamin A alcohol (VAN)
Vitamin- A alcohol solution
Vitamin A cryst
Vitamin A1
Vitamin- A1
Vitamin A1 alcohol
Vitamin A1 alcohol, all trans
Vitamin-?A
Vitamin-?A alcohol
Vitamin-?A alcohol solution
Vitamin-?A1
Vitamine A
Vitaminum A
Vitavel A
Vitavel-A
Vitpex
Vogan
Vogan-Neu
Vogan-nu
Wachstumsvitamin
WLN: L6UTJ A1 B1U1Y1&U2U1Y1&U2Q C1 C1
ZINC03831417
Zinosan N
|
|
17 |
|
Prednisolone hemisuccinate |
Experimental |
Phase 4 |
|
2920-86-7 |
|
Synonyms:
(+)-prednisolone hemisuccinate
Prednisolonbisuccinat
Prednisolone 21-hemisuccinate
Prednisolone 21-succinate
|
Prednisolone bisuccinate
Prednisolone hydrogen succinate
Prednisolone succinate
|
|
18 |
|
Phosphodiesterase Inhibitors |
|
Phase 4 |
|
|
|
19 |
|
Phosphodiesterase 3 Inhibitors |
|
Phase 4 |
|
|
|
20 |
|
Neuroprotective Agents |
|
Phase 4 |
|
|
|
21 |
|
Vasodilator Agents |
|
Phase 4 |
|
|
|
22 |
|
Platelet Aggregation Inhibitors |
|
Phase 4 |
|
|
|
23 |
|
Protective Agents |
|
Phase 4 |
|
|
|
24 |
|
Hormone Antagonists |
|
Phase 4 |
|
|
|
25 |
|
abobotulinumtoxinA |
|
Phase 4 |
|
|
|
26 |
|
Botulinum Toxins, Type A |
|
Phase 4 |
|
|
|
27 |
|
Botulinum Toxins |
|
Phase 4 |
|
|
|
28 |
|
Gastrointestinal Agents |
|
Phase 4 |
|
|
|
29 |
|
Antioxidants |
|
Phase 4 |
|
|
|
30 |
|
Serotonin Uptake Inhibitors |
|
Phase 4 |
|
|
|
31 |
|
Alpha-lipoic Acid |
|
Phase 4 |
|
|
|
32 |
|
Thioctic Acid |
|
Phase 4 |
|
|
|
33 |
|
Antineoplastic Agents, Hormonal |
|
Phase 4 |
|
|
|
34 |
|
glucocorticoids |
|
Phase 4 |
|
|
|
35 |
|
Anti-Inflammatory Agents |
|
Phase 4 |
|
|
|
36 |
|
Antidepressive Agents, Tricyclic |
|
Phase 4 |
|
|
|
37 |
|
Antiemetics |
|
Phase 4 |
|
|
|
38 |
|
Linoleate |
|
Phase 4 |
|
|
|
39 |
|
Methylprednisolone Acetate |
|
Phase 4 |
|
|
|
40 |
|
Phosphodiesterase 5 Inhibitors |
|
Phase 4 |
|
|
|
41 |
|
retinol |
|
Phase 4 |
|
|
|
42 |
|
Retinol palmitate |
|
Phase 4 |
|
|
|
43 |
|
Immunoglobulin G |
|
Phase 4 |
|
|
|
44 |
|
Antibodies |
|
Phase 4 |
|
|
|
45 |
|
Immunoglobulins, Intravenous |
|
Phase 4 |
|
|
|
46 |
|
Immunoglobulins |
|
Phase 4 |
|
|
|
47 |
|
Immunologic Factors |
|
Phase 4 |
|
|
|
48 |
|
Testosterone enanthate |
Approved |
Phase 2, Phase 3 |
|
315-37-7 |
9416 |
Synonyms:
17-((1-Oxoheptyl)oxy)androst-4-en-3-one
17beta-Enanthoxyandrost-4-en-3-one
17beta-Hydroxyandrost-4-en-3-one enanthate
17beta-Hydroxyandrost-4-en-3-one heptanoate
17beta-Hydroxyandrost-4-en-3-one heptanoic acid
17b-Hydroxyandrost-4-en-3-one heptanoate
17b-Hydroxyandrost-4-en-3-one heptanoic acid
17-Hydroxyandrost-4-en-3-one, 17-heptanoate
17-Hydroxyandrost-4-en-3-one, 17-heptanoic acid
17β-hydroxyandrost-4-en-3-one heptanoate
17β-hydroxyandrost-4-en-3-one heptanoic acid
4-Androsten-17beta-ol-3-one 17-enanthate
4-Androsten-3-one 17beta-enanthate
Androgyn l.a.
Andropository
Androtardyl
Atlatest
BTG Brand OF testosterone enanthate
DEA no. 4000
Delatest
Delatestryl
DePatestrye
depo-testro Med
Ditate
Durathate
eifelfango Brand OF testosterone enanthate
Everone
Exten test
Jenapharm brand OF testosterone enanthate
Malogen l.a.
Malogen l.a.200
Orquisteron-e
Pasadena brand OF testosterone enanthate
|
Primoteston depot
Primotestone
reposo TMD
Roberts brand OF testosterone enanthate
Rotexmedica brand OF testosterone enanthate
Rugby brand OF testosterone enanthate
Schering brand OF testosterone enanthate
Testanthate
Testate
Testenate
Testinon
Testoenant
Testonenant
Testosteron depot-rotexmedica
Testosteron-depot eifelfango
Testosteron-depot jenapharm
Testosterone 17beta-heptanoate
Testosterone 17beta-heptanoic acid
Testosterone 17-enanthate
Testosterone 17-enanthic acid
Testosterone enantate
Testosterone enanthic acid
Testosterone heptanoate
Testosterone heptanoic acid
Testosterone heptoate
Testosterone heptoic acid
Testosterone heptylate
Testosterone oenanthate
Testostroval
Testrin p.a.
Theramed brand OF testosterone enanthate
Theramex
|
|
49 |
|
Testosterone undecanoate |
Approved, Investigational |
Phase 2, Phase 3 |
|
5949-44-0 |
|
Synonyms:
Testosterone undecanoate
Testosterone undeconate
|
|
|
50 |
|
Testosterone |
Approved, Experimental, Investigational |
Phase 2, Phase 3 |
|
58-22-0, 481-30-1 |
10204 6013 |
Synonyms:
(17-alpha)-17-Hydroxyandrost-4-en-3-one
(17beta)-17-Hydroxyandrost-4-en-3-one
(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
17 alpha Testosterone
17?-Hydroxy-4-androsten-3-one
17a-cis-Testosterone
17alpha-cis-Testosterone
17-alpha-Hydroxyandrost-4-en-3-one
17-alpha-Testosterone
17beta-Hydroxy-3-oxo-4-androstene
17beta-hydroxy-4-androsten-3-one
17beta-Hydroxy-4-androsten-3-one
17beta-Hydroxyandrost-4-en-3-one
17-beta-Hydroxyandrost-4-en-3-one
17beta-Hydroxyandrost-4-ene-3-one
17-beta-Hydroxy-delta(sup 4)-androsten-3-one
17beta-Hydroxy-delta(sup4)-androsten-3-one
17b-hydroxy-4-androsten-3-one
17-Epitestosterone
17-Hydroxy-(17beta)-androst-4-en-3-one
17-Hydroxy-(17-beta)-androst-4-en-3-one
46923_FLUKA
46923_RIEDEL
4-Androsten-17?-ol-3-one
4-Androsten-17beta-ol-3-one
4-androsten-17β-ol-3-one
4-androstene-17beta-ol-3-one
58-22-0
7-beta-Hydroxyandrost-4-en-3-one
AA 2500
AC-14899
AC1L1LM0
Andriol
Andro
Andro 100
Andro L.A. 200
Androderm
Androderm (TN)
Androgel
AndroGel
Androgel (TN)
Android 10
Android 25
Android 5
Androlin
Andronaq
Andronate 100
Andronate 200
Andropatch
Andropository 200
Androsorb
Androst-4-en-17beta-ol-3-one
Andrusol
Andryl 200
B5DEE83F-632B-48A1-A0ED-A51E7F13DF2E
beta testosterone
Beta Testosterone
BIDD:ER0555
BIM-0061761.0001
Bio-0678
Bio-T-Gel
C00535
CCRIS 574
CDB 111C
CHEBI:17347
CHEMBL386630
CID6013
cis-Testosterone
CMC_13449
COL 1621
CP 601B
CPD000058344
Cristerona T
Cristerone T
D00075
DB00624
Dea No. 4000
Delatest
Delatestryl
delta(sup 4)-Androsten-17(beta)-ol-3-one
delta4-Androsten-17beta-ol-3-one
delta4-androsten-17b-ol-3-one
Depotest
Depo-Testosterone
Depo-Testosterone Cypionate
EINECS 200-370-5
Epi-testosterone
Everone 200
Geno-cristaux gremy
Geno-Cristaux Gremy
Halotensin
HMS2052N11
Homosteron
Homosterone
HSDB 3398
Intrinsa
Isotestosterone
Libigel
LibiGel
LMST02020002
LS-148813
|
Malerone
Malestrone
Malestrone (amps)
Malogen in Oil
Malogen, aquaspension injection
Malogen, Aquaspension Injection
Mertestate
Metandren
Methyltestosterone
MLS000563091
MLS001032098
MLS001306401
MLS002174283
MolPort-002-506-901
NCGC00091018-01
Neo-Hombreol F
Neotestis
Neo-testis
Neo-Testis
NSC 9700
Oreton
Oreton F
Oreton Methyl
Oreton-F
Orquisteron
Perandren
Percutacrine androgenique
Percutacrine Androgenique
Primotest
Primoteston
Relibra
S00309
S2033_Selleck
SAM001246921
Scheinpharm Testone-Cyp
SMR000058344
SMR001261453
Striant
Striant (TN)
Sustanon
Sustanone
Sustason 250
Synandrol F
T1500_SIGMA
T5411_FLUKA
T5411_SIGMA
T-Cypionate
TES
Teslen
Testamone 100
Testandrone
Testaqua
Testiculosterone
Testim
Testim (TN)
Testobase
Testoderm
Testoderm Tts
Testogel
Testoject-50
Testolin
Testopel Pellets
Testopropon
Testosteroid
Testosteron
Testosterona
Testosterona [INN-Spanish]
testosterone
Testosterone
Testostérone
Testosterone (JAN/USP)
Testosterone [Androgenic steroids, anabolic]
Testosterone [INN:BAN]
Testosterone and its esters
Testosterone Cypionate
Testosterone Enanthate
Testosterone hydrate
Testosterone Hydrate
Testosterone solution
Testosteronum
Testosteronum [INN-Latin]
Testostosterone
Testoviron
Testoviron Schering
Testoviron T
Testred
Testred Cypionate 200
Testrin-P.A
Testro Aq
Testro AQ
Testrone
Testryl
trans-Testosterone
Trans-Testosterone
UNII-3XMK78S47O
Virilon
Virilon IM
Virormone
Virosterone
ZINC06500184
|
|
Interventional clinical trials:
(show top 50)
(show all 334)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Randomised, Double-blind, Placebo-controlled Trial of the Effect of the Combination of Imipramine and Pregabalin for the Treatment of Painful Polyneuropathy |
Unknown status |
NCT01047488 |
Phase 4 |
Imipramine;Pregabalin;Imipramine, pregabalin;Placebo |
2 |
Treatment With Gamunex 10% Intravenous Immunoglobulin (IVIg) for Patients With Demyelination and Diabetes Mellitus: A Blinded, Placebo-Controlled Crossover Pilot Study |
Unknown status |
NCT02372149 |
Phase 4 |
10% intravenous immunoglobulin (IVIg);0.9% sodium chloride |
3 |
Muscular Electrostimulation of the Sedated and Mechanically Ventilated Critically Ill Patient. Analysis of the Effect on Acquired Muscular Weakness and Its Clinical Consequences. |
Unknown status |
NCT02033057 |
Phase 4 |
|
4 |
Evaluation of the Impact of Subject and Staff Training on the Pregabalin vs. Placebo Difference in Subjects With Painful Diabetic Neuropathy (PDN) |
Unknown status |
NCT01770964 |
Phase 4 |
Pregabalin;placebo |
5 |
Effects of Pregabalin on Mechanical Hyperalgesia - EPOM |
Unknown status |
NCT00310583 |
Phase 4 |
Pregabalin |
6 |
Asian Study on Cilostazol Effectivity in Neuropathies of Diabetes Mellitus Type 2-A Pilot Study in the Philippines |
Completed |
NCT01076478 |
Phase 4 |
Cilostazol |
7 |
Double-blind, Randomised, Placebo-controlled Trial of the Effect of Levetiracetam on Painful Polyneuropathy |
Completed |
NCT00286260 |
Phase 4 |
levetiracetam |
8 |
Escitalopram as a Treatment for Pain in Polyneuropathy. A Double-Blind, Randomized, Placebo Controlled Trial. |
Completed |
NCT00162968 |
Phase 4 |
escitalopram |
9 |
Oxcarbazepine for the Treatment of Chronic Peripheral Neuropathic Pain: Predictors of Response - a Randomised, Double-blind, Placebo-controlled Clinical Trial |
Completed |
NCT01302275 |
Phase 4 |
Oxcarbazepine |
10 |
Qutenza Versus Pregabalin in Subjects With Peripheral Neuropathic Pain: an Open-label, Randomized, Multicenter, Non-inferiority Efficacy and Tolerability Study |
Completed |
NCT01713426 |
Phase 4 |
Qutenza;Pregabalin |
11 |
Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations (PAIN-CONTRoLS) |
Completed |
NCT02260388 |
Phase 4 |
Nortriptyline;Duloxetine;Pregabalin;Mexiletine |
12 |
A Prospective, Open-label Trial of Lidoderm® (Lidocaine Patch 5%)in Painful Diabetic and Idiopathic Neuropathy. |
Completed |
NCT00903851 |
Phase 4 |
Lidoderm |
13 |
A 12-week, Multi-center, Randomized, Double-blind, Double Dummy, Parallel Clinical Trial to Compare the Efficacy of γ-linolenic Acid and Thioctic Acid in Patients With Diabetic Neuropathy |
Completed |
NCT03914404 |
Phase 4 |
γ-linoleic acid and placebo(Thioctic Acid);Thioctic Acid and placebo(γ-linoleic acid) |
14 |
Randomized Double Blind Placebo Controlled Multicenter Study of the Efficacy and Safety of Repeated Administrations of Botulinum Toxin Type A (Botox) in the Treatment of Peripheral Neuropathic Pain |
Completed |
NCT01251211 |
Phase 4 |
botulinum toxin type A |
15 |
A Phase IV Clinical Trial. Effect of Pulsing Electromagnetic Fields on Lower Extremity Diabetic Neuropathy: A Pilot, Open-Label Study |
Completed |
NCT00614341 |
Phase 4 |
|
16 |
Phase II Study To Evaluate The Safety And Efficacy Of Lenalidomide For The Treatment Of Refractory Cutaneous Lupus |
Completed |
NCT01408199 |
Phase 4 |
Lenalidomide |
17 |
Treatment With Alpha-lipoic Acid Over 16 Weeks in Type 2 Diabetic Patients With Symptomatic Polyneuropathy Who Responded to Initial 4-week High-dose Loading |
Completed |
NCT02439879 |
Phase 4 |
Alpha lipoic acid |
18 |
Long Term, Double Blind, Randomized, Placebo Controlled Multi-center Study of FRE.M.S.- Frequency Modulated Neural Stimulation Lorenz Therapy™ in Symptomatic Diabetic Neuropathy |
Completed |
NCT01628627 |
Phase 4 |
|
19 |
Phase IV Study on New Insights in Remodeling of Diabetic Cardiomyopathy: Gender Difference in Intramyocardial, Molecular and Neuroendocrine Assessment in Response to Chronic Inhibition of Cyclic GMP Phosphodiesterase 5A |
Completed |
NCT01803828 |
Phase 4 |
Tadalafil;Placebo |
20 |
Comparison of the Efficacy of Corticosteroid Injection and Extracorporeal Shock Wave Therapy (ESWT) in Patients With Carpal Tunnel Syndrome; A Prospective Randomized Controlled Trial |
Completed |
NCT03792945 |
Phase 4 |
local injection |
21 |
Local Steroid Injection vs Wrist Splinting for Carpal Tunnel Syndrome: A Randomized Clinical Trial |
Completed |
NCT02140632 |
Phase 4 |
|
22 |
Randomized Study of Single vs. Multiple Privigen Dose Regimens in Pediatric CIDP |
Active, not recruiting |
NCT03684018 |
Phase 4 |
|
23 |
A Phase 4 Safety Study Assessing the Adverse Events Occurring Within One Day of TEGSEDI Administration in Patients With Polyneuropathy of Hereditary Transthyretin-mediated Amyloidosis (hATTR-PN) |
Not yet recruiting |
NCT04306510 |
Phase 4 |
|
24 |
A Double-blind, Placebo-controlled, Cross-over Study of Ranolazine in Patients With Coronary Artery Disease for the Treatment of Painful Polyneuropathy |
Terminated |
NCT00832572 |
Phase 4 |
Ranolazine;Placebo |
25 |
Efficacy, Safety, Tolerability and Pharmacokinetics of Concomitant Administration of Tramadol With Duloxetine or Pregabalin: a Randomized Controlled Flexible-dose Study in Patients With Neuropathic Pain |
Withdrawn |
NCT01116531 |
Phase 4 |
Tramadol;Duloxetine;Pregabalin |
26 |
Effect of Pioglitazone on Intima Media Thickness, Endothelial Function, and Heart Rate Variability in Patients With Impaired Glucose Tolerance |
Withdrawn |
NCT00306826 |
Phase 4 |
pioglitazone;simvastatin;pioglitazone + simvastatin |
27 |
Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Study to Evaluate the Efficacy and Safety of Thioctacid Oral Tablet 600mg Once Daily in Chinese Diabetic Patients With Distal Symmetric Polyneuropathy |
Unknown status |
NCT01224353 |
Phase 2, Phase 3 |
lipoic acid |
28 |
Neuromuscular Electrical Stimulation for Intensive Care Unit-acquired Weakness |
Unknown status |
NCT02706587 |
Phase 3 |
|
29 |
Prospective, Open-Label, Phase IIIb Study Evaluating the Safety, Tolerability and Efficacy of Panzyga® in Patients With Chronic Inflammatory Demyelinating Polyneuropathy Administered at Standard and High Infusion Rates |
Unknown status |
NCT03166527 |
Phase 3 |
Immune Globulin 10% Intravenous Solution |
30 |
Effects of Benfotiamine on Intraepidermal Nerve Fiber Density (IENFD)and Diabetic Neuropathy in Subjects With Sensorimotor Diabetic Polyneuropathy: a Double-blind, Randomized, Placebo-controlled Parallel Group Pilot Study Over 12 Months. |
Unknown status |
NCT01868191 |
Phase 3 |
Benfotiamine;Placebo for benfotiamine |
31 |
Pilot Randomized, Controlled Trial of Testosterone Therapy in Chronic Critically Ill Patients and Its Potential Effects on Weaning From Mechanical Ventilation and Intensive Care Unit-acquired Weakness |
Unknown status |
NCT03038919 |
Phase 2, Phase 3 |
Testosterone cypionate |
32 |
A Single-arm Study to Demonstrate the Efficacy and Safety of Privigen in the Treatment of Subjects With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) |
Completed |
NCT01184846 |
Phase 3 |
|
33 |
Safety and Efficacy of AS-3201 in the Treatment of Diabetic Sensorimotor Polyneuropathy |
Completed |
NCT00101426 |
Phase 3 |
ranirestat, (AS-3201) |
34 |
A Multi-centre, Double-blind, Placebo-controlled, Randomised, Parallel Group Clinical Trial to Evaluate Efficacy and Safety of Actovegin® in Diabetic Type 2 Patients With Symptomatic Diabetic Peripheral Polyneuropathy |
Completed |
NCT00483730 |
Phase 3 |
Deproteinised hemoderivative of calf blood (Actovegin) |
35 |
The Effect On Transthyretin Stabilization, Safety, Tolerablity, Efficacy And Pharmacokinetics Of Orally Administered Tafamidis In Transthyretin Amyloid Polyneuropathy Patients With V30m Or Non-v30m Transthyretin: A Phase Iii, Open-label Study |
Completed |
NCT01435655 |
Phase 3 |
tafamidis |
36 |
A 2-year, Randomized, Double-blind, Placebo-controlled, Multi-center, Phase II-III Study to Evaluate the Efficacy and Safety of Oral Ranirestat (40 and 80 mg) in Mild to Moderate Diabetic Sensorimotor Polyneuropathy |
Completed |
NCT00927914 |
Phase 2, Phase 3 |
Ranirestat;Placebo |
37 |
NPB-01(Intravenous Immunoglobulin) Maintenance Therapy for Patients With Chronic Inflammatory Demyelinating Polyneuropathy. |
Completed |
NCT01824251 |
Phase 3 |
NPB-01 |
38 |
Double-blind Randomized Trial of Rituximab Versus Placebo in Polyneuropathy Associated With Anti-MAG IgM Monoclonal Gammopathy |
Completed |
NCT00259974 |
Phase 3 |
Rituximab |
39 |
APOLLO: A Phase 3 Multicenter, Multinational, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Patisiran (ALN-TTR02) in Transthyretin (TTR)-Mediated Polyneuropathy (Familial Amyloidotic Polyneuropathy-FAP) |
Completed |
NCT01960348 |
Phase 3 |
patisiran (ALN-TTR02);Sterile Normal Saline (0.9% NaCl) |
40 |
Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2) NATHAN1 A Randomized, Placebo-controlled, Double-blind Multi-centre Trial With 2 Parallel Groups |
Completed |
NCT00977483 |
Phase 3 |
Thioctic Acid;Placebo |
41 |
A Randomized, Crossover, Double Blinded, Placebo Controlled Trial of Topical Capsaicin in Treatment of Painful Diabetic Neuropathy |
Completed |
NCT00993070 |
Phase 2, Phase 3 |
Capsaicin;placebo |
42 |
Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Symptomatic Diabetic Neuropathy (SYDNEY 2) Randomised, Double-Blind,Placebo-Controlled Multicentre Trial With 4 Parallel Groups |
Completed |
NCT00328601 |
Phase 3 |
Thioctic Acid |
43 |
Multicentre Randomized Open-label Trial to Compare Efficacy and Tolerance of Corticosteroids and IVIg in Patients With Chronic Inflammatory Demyelinating Polyneuropathy on a One Year Follow up |
Completed |
NCT01349270 |
Phase 3 |
Immunoglobulin perfusion;Prednisone |
44 |
A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of ISIS 420915 in Patients With Familial Amyloid Polyneuropathy (NEURO-TTR Study) |
Completed |
NCT01737398 |
Phase 2, Phase 3 |
Inotersen;Placebo |
45 |
The Effect of Diflunisal on Familial Amyloidosis |
Completed |
NCT00294671 |
Phase 2, Phase 3 |
diflunisal |
46 |
Multicenter, Open-label Extension Study to Investigate the Long-term Safety and Efficacy of IgPro20 in Maintenance Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in Subjects Completing Study IgPro20_3003 |
Completed |
NCT02027701 |
Phase 3 |
|
47 |
Neuropathic Pain Treatment Using F0434 vs. Gabapentin in Patients With Chronic Distal Diabetic Polyneuropathy: A Randomized, Controlled, Double-blind Study |
Completed |
NCT01263132 |
Phase 3 |
F0434;Gabapentin |
48 |
Safety and Efficacy of Orally Administered Fx-1006A in Patients With Familial Amyloid Polyneuropathy (FAP): A Randomized, Double-blind, Placebo-controlled Study |
Completed |
NCT00409175 |
Phase 2, Phase 3 |
Fx-1006A;Placebo |
49 |
Dietetic and Hygiene Measures in Metabolic Neuropathies: the Neurodiet Study |
Completed |
NCT01465620 |
Phase 3 |
|
50 |
Randomized, Multicenter, Double-blind, Placebo-controlled, Parallel-group Phase III Study to Investigate the Efficacy, Safety, and Tolerability of 2 Different Doses of IgPro20 (Subcutaneous Immunoglobulin) for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - the PATH Study |
Completed |
NCT01545076 |
Phase 3 |
|
Cochrane evidence based reviews: polyneuropathies
|